Knoles v. Teva Pharmaceuticals USA, Inc.
Opinion
1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 MARLESSA KNOLES, Case No. 17-cv-06580-BLF
8 Plaintiff, ORDER DISMISSING SECOND 9 v. AMENDED COMPLAINT AS TO ALL REMAINING DEFENDANTS; AND 10 TEVA PHARMACEUTICALS USA, INC.; DISMISSING ACTION WITHOUT TEVA BRANDED PHARMACEUTICALS PREJUDICE 11 PRODUCTS R&D, INC.; FEI WOMEN’S HEALTH LLC; ORTHO-MCNEIL 12 PHARMACEUTICAL, LLC; and DURAMED PHARMACEUTICALS, 13 Defendants. 14 15 16 On October 17, 2019, the Court granted the Teva Defendants’ motion to dismiss the 17 second amended complaint (“SAC”) for lack of personal jurisdiction, without leave to amend. See 18 Order, ECF 81. 19 The Court also ordered Plaintiff to show cause, in writing and on or before October 31, 20 2019, why the second amended complaint should not be dismissed with respect to the three 21 remaining defendants, FEI Women’s Health LLC, Ortho-McNeil Pharmaceutical, LLC, and 22 Duramed Pharmaceuticals. See Order, ECF 81. The Court stated its view that these defendants 23 are subject to dismissal on the bases that they were added in violation of the Court’s express order 24 and they have not been timely served with process as required under Federal Rule of Civil 25 Procedure 4(m). See id. 26 Plaintiff has not responded to the Order to Show Cause and the deadline for response has 27 elapsed. The Court finds that dismissal of the second amended complaint with respect to the 1 Federal Rule of Civil Procedure 41(b) allows for involuntary dismissal of an action “[i]f 2 the plaintiff fails to prosecute or to comply with these rules or a court order.” Rule 41(b) permits a 3 court to dismiss an action sua sponte. See Link v. Wabash R.R. Co., 370 U.S. 626, 630-31 (1962). 4 Before imposing dismissal as a sanction, “the district court must consider five factors: (1) the 5 public’s interest in expeditious resolution of litigation; (2) the court’s need to manage its docket; 6 (3) the risk of prejudice to the defendants; (4) the public policy favoring disposition of cases on 7 their merits; and (5) the availability of less drastic alternatives.” Yourish v. Calif. Amplifier, 191 8 F.3d 983, 990 (9th Cir. 1999) (internal quotation marks and citation omitted). 9 Plaintiff has failed to comply with this Court’s orders or with the service requirements of 10 Rule 4(m). In its Order Granting Motion to Substitute, the Court granted Plaintiff’s request for 11 leave to amend to add “Paragard” as a defendant. See Order Granting Motion to Substitute, ECF 12 70. The order prohibited Plaintiff from adding any other new parties or claims without express 13 leave of the Court. See id. Plaintiff nonetheless filed her SAC adding Defendants FEI Women’s 14 Health LLC, Ortho-McNeil Pharmaceutical, LLC, and Duramed Pharmaceuticals, in direct 15 contravention of the Court’s explicit order. See SAC, ECF 71. Plaintiff then failed to effect 16 service of process on these defendants within 90 days of filing her SAC, as required under Rule 17 4(m). See Fed. R. Civ. P. 4(m) (requiring service of process within 90 days after complaint is 18 filed). Plaintiff also failed to respond to the Court’s Order to Show Cause why the SAC should 19 not be dismissed as to Defendants FEI Women’s Health LLC, Ortho-McNeil Pharmaceutical, 20 LLC, and Duramed Pharmaceuticals. 21 Plaintiff’s failure to comply with the Court’s orders and with Rule 4(m) can serve as 22 grounds for dismissal if the factors set forth above favor dismissal. See Yourish, 191 F.3d at 986. 23 Here, four of the five factors strongly favor dismissal. Dismissal serves the public’s interest in 24 expeditious resolution of litigation (factor 1), because Plaintiff’s failure to serve the SAC on the 25 remaining defendants and failure to respond to the Court’s Order to Show Cause effectively have 26 stalled the case. Plaintiff’s conduct has interfered with the Court’s need to manage its docket 27 (factor 2), because Plaintiff has ignored the Court’s orders and the requirements of the Federal 1 (factor 3), who are entitled to notice and resolution of Plaintiffs claims. The public policy 2 || favoring disposition of cases on their merits (factor 4) does not favor dismissal. However, the 3 Court sees little point in imposing less severe sanctions (factor 5), because Plaintiff has shown no 4 || interest in complying with this Court’s orders or with Rule 4m). Accordingly, the Court 5 concludes that the SAC is subject to dismiss as to all remaining defendants under Rule 41(b). 6 In addition, Rule 4(m) provides an independent basis for dismissal. The rule provides that 7 “Ti]f a defendant is not served within 90 days after the complaint is filed, the court — on motion or 8 on its own after notice to the plaintiff — must dismiss the action without prejudice against that 9 || defendant or order that service be made within a specified time.” Fed. R. Civ. P. 4(m). The 10 || Court’s Order to Show Cause gave Plaintiff notice that the Court was considering dismissal of the 11 SAC as to all remaining defendants for failure to effect service of process within 90 days. See 12 Order, ECF 81. Plaintiff failed to ask for additional time or otherwise respond. 5 13 For these reasons, the SAC is DISMISSED as to Defendants FE] Women’s Health LLC, 14 Ortho-McNeil Pharmaceutical, LLC, and Duramed Pharmaceuticals. 3 15 The SAC having been dismissed as to the Teva Defendants for lack of personal 16 || jurisdiction, and as to the remaining Defendants for failure to prosecute and failure to effect 3 17 service of process, the action is hereby DISMISSED WITHOUT PREJUDICE as to all 18 Defendants. 19 The Clerk shall close the file. 20 IT IS SO ORDERED. 21 22 Dated: November 5, 2019 gy han tn) 23 M. BETH LABSON FREEMAN 24 United States District Judge 25 26 27 28
Free access — add to your briefcase to read the full text and ask questions with AI
Knoles v. Teva Pharmaceuticals USA, Inc. (Knoles v. Teva Pharmaceuticals USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.